SPOTLIGHT -
May 16th 2024
Industry experts gather to discuss the current investor market and how the IRA may impact the industry in the coming years.
May 15th 2024
Novo Holdings is expected to acquire 60% of Single Use Support, with the remaining shares being held by Danaher and the company founders.
May 14th 2024
The joint venture aims to address unmet needs in the treatment of mood and anxiety disorders through novel neuroplastogens.
May 13th 2024
Led by Decheng Capital, the successful round of funding also included participation from investors such as Cormorant Asset Management, Surveyor Capital, and the Foundation for Prader-Willi Research.
These factors provide investors with enough information to identify promising investment opportunities.
Finance: Q&A with Annette Grimaldi
The latest dealmaking trends: Early-stage is back in favor. There's more money to be made in being acquired than in going public. And license deals are putting more on the back end.
Finance: Promotional Productivity
Lovenox still needs a defense strategy to hold share, but it requires less investment as a specialty product. Instead, Lovenox should throw cash over to Acomplia, the putative future star of the Sanofi-Aventis portfolio.